CAS: 81525-10-2; 6-Carbamimidoylnaphthalen-2-Yl 4-Guanidinobenzoate

该化合物是一种主要用于医疗应用的合成精液蛋白抑制剂,特别是用于治疗胰腺炎和在某些外科手术过程中用作抗凝胶剂的合成精液抑制剂,其作用是抑制各种蛋白质,包括试剂和抽血素,它们对于血液凝聚和炎症起着关键作用.Nafalposat的特征是其行动迅速,其半衰期相对较短,需要不断注入持续的治疗效果.该化合物通常通过静脉注射进行,原因是其口服生物利用率低.其化学结构包括一种独特的功能组群,这些组群有助于其抑制性能,使其在调节配制配方性活动方面产生效力.此外,Nafalostat还因其潜在的抗病毒性能,特别是在COVID-19的情况下,引起人们的注意,因为它可能会通过针对宿主细胞蛋白来抑制病毒进入.但是,其使用与潜在的副作用有关,包括出血和过敏反应,因此需要在管理期间进行仔细监测.

结构式图片

合成工艺路线路线简述

  • 1184-90-3 + 150-13-0 = 81525-10-2 + 75-75-2
    反应条件:1.1 Reagents: Potassium Carbonate Solvents: Water; 0.5 H,Rt1.2 Reagents: Hydrochloric Acid Solvents: Methanol; 0.5 H,Rt2.1 Reagents: Cyanuric Chloride,4-Methylmorpholine; 4 H,60 °C2.2 Overnight,Rt2.3 Reagents: Sodium Bicarbonate Solvents: Water; 10 Min,Rt2.4 Solvents: Methanol
    标题:Tct-Mediated Process For The Preparation Of Nafamostat Mesylate And Camostat Mesylate
    作者:Ahmed,Riyaz; Et Al
    参考文献:Chemistryselect 日期:2023 卷标:8(18)]

    150-13-0 + 420-04-2 = 81525-10-2 + 75-75-2
    反应条件:1.1 Reagents: Hydrochloric Acid Solvents: Water1.2 -2.1 Reagents: Dicyclohexylcarbodiimide Catalysts: 4-(Dimethylamino)Pyridine Solvents: Pyridine; 5 H,Rt2.2 Reagents: Sodium Bicarbonate Solvents: Water2.3 Solvents: Methanol; Cooled; 0.5 H,Rt2.4 Reagents: Diethyl Ether
    标题:Synthesis Of 4-[(Aminoiminomethyl)Amino]Benzoic Acid 6-(Aminoiminomethyl)-2-Naphthalenyl Ester,Methanesulfonate (1:2) (Nafamostat Mesilate)
    作者:Chen,Baoquan; Et Al
    参考文献:Zhongguo Yiyao Gongye Zazhi 日期:2007 卷标:38(8) 页码:545-546]

    52927-22-7 + 75-75-2 = 81525-10-2 + 75-75-2
    反应条件:1.1 Reagents: Hydrochloric Acid Solvents: Methanol,Water; Overnight,Rt1.2 Reagents: Ammonia Solvents: Methanol; 3 H,50 °C1.3 Reagents: Sodium Bicarbonate Solvents: Water; 15 Min,Rt1.4 Solvents: Methanol2.1 Reagents: Cyanuric Chloride,4-Methylmorpholine; 4 H,60 °C2.2 Overnight,Rt2.3 Reagents: Sodium Bicarbonate Solvents: Water; 10 Min,Rt2.4 Solvents: Methanol
    标题:Tct-Mediated Process For The Preparation Of Nafamostat Mesylate And Camostat Mesylate
    作者:Ahmed,Riyaz; Et Al
    参考文献:Chemistryselect 日期:2023 卷标:8(18)]

    15231-91-1 = 81525-10-2 + 75-75-2
    反应条件:1.1 Solvents: Dimethylformamide; 5 - 6 H,150 °C; 150 °C -> Rt1.2 Reagents: Sodium Hydroxide; 5 Min,Rt1.3 Reagents: Hydrochloric Acid Solvents: Water; Ph 2 - 32.1 Reagents: Hydrochloric Acid Solvents: Methanol,Water; Overnight,Rt2.2 Reagents: Ammonia Solvents: Methanol; 3 H,50 °C2.3 Reagents: Sodium Bicarbonate Solvents: Water; 15 Min,Rt2.4 Solvents: Methanol3.1 Reagents: Cyanuric Chloride,4-Methylmorpholine; 4 H,60 °C3.2 Overnight,Rt3.3 Reagents: Sodium Bicarbonate Solvents: Water; 10 Min,Rt3.4 Solvents: Methanol
    标题:Tct-Mediated Process For The Preparation Of Nafamostat Mesylate And Camostat Mesylate
    作者:Ahmed,Riyaz; Et Al
    参考文献:Chemistryselect 日期:2023 卷标:8(18)]

    58200-88-7 + 56-91-7 + 75-75-2 = 81525-10-2
    反应条件:1.1 Reagents: Dicyclohexylcarbodiimide Solvents: Pyridine
    标题:Synthesis And Structure-Activity Study Of Protease Inhibitors. Iv. Amidinonaphthols And Related Acyl Derivatives
    作者:Aoyama,Takuo; Et Al
    参考文献:Chemical & Pharmaceutical Bulletin 日期:1985 卷标:33(4) 页码:1458-71]

    16060-65-4 = 81525-10-2 [标题:Reaction Conditions
    标题:Amidine Compounds And Anticomplement Agent Comprising Them
    参考文献:European Patent Organization]

    58200-88-7 + 42823-46-1 + 75-75-2 = 81525-10-2 + 75-75-2
    反应条件:1.1 Reagents: Cyanuric Chloride,4-Methylmorpholine; 4 H,60 °C1.2 Overnight,Rt1.3 Reagents: Sodium Bicarbonate Solvents: Water; 10 Min,Rt1.4 Solvents: Methanol
    标题:Tct-Mediated Process For The Preparation Of Nafamostat Mesylate And Camostat Mesylate
    作者:Ahmed,Riyaz; Et Al
    参考文献:Chemistryselect 日期:2023 卷标:8(18)]

    15231-91-1 = 81525-10-2 + 75-75-2
    反应条件:1.1 Solvents: Dimethylformamide2.1 Reagents: Hydrochloric Acid Solvents: Ethanol; Cooled; Overnight,Rt2.2 Reagents: Ammonia Solvents: Ethanol; 3 H,50 °C2.3 Reagents: Sodium Bicarbonate Solvents: Water2.4 Solvents: Methanol; Cooled; 0.5 H,Rt2.5 Reagents: Diethyl Ether3.1 Reagents: Dicyclohexylcarbodiimide Catalysts: 4-(Dimethylamino)Pyridine Solvents: Pyridine; 5 H,Rt3.2 Reagents: Sodium Bicarbonate Solvents: Water3.3 Solvents: Methanol; Cooled; 0.5 H,Rt3.4 Reagents: Diethyl Ether
    标题:Synthesis Of 4-[(Aminoiminomethyl)Amino]Benzoic Acid 6-(Aminoiminomethyl)-2-Naphthalenyl Ester,Methanesulfonate (1:2) (Nafamostat Mesilate)
    作者:Chen,Baoquan; Et Al
    参考文献:Zhongguo Yiyao Gongye Zazhi 日期:2007 卷标:38(8) 页码:545-546]

    1758-73-2 = 81525-10-2 + 75-75-2
    反应条件:1.1 Solvents: Peracetic Acid; 0.5 H,0 °C; 0 °C -> Rt; Overnight,Rt2.1 Reagents: Potassium Carbonate Solvents: Water; 0.5 H,Rt2.2 Reagents: Hydrochloric Acid Solvents: Methanol; 0.5 H,Rt3.1 Reagents: Cyanuric Chloride,4-Methylmorpholine; 4 H,60 °C3.2 Overnight,Rt3.3 Reagents: Sodium Bicarbonate Solvents: Water; 10 Min,Rt3.4 Solvents: Methanol
    标题:Tct-Mediated Process For The Preparation Of Nafamostat Mesylate And Camostat Mesylate
    作者:Ahmed,Riyaz; Et Al
    参考文献:Chemistryselect 日期:2023 卷标:8(18)]

    135-19-3 = 81525-10-2 + 75-75-2
    反应条件:1.1 Reagents: Bromine Solvents: Acetic Acid; 15 - 30 Min,Rt1.2 Solvents: Water; 3 - 4 H,120 °C; 120 °C -> 100 °C1.3 Reagents: Tin; 3 H,Reflux2.1 Solvents: Dimethylformamide; 5 - 6 H,150 °C; 150 °C -> Rt2.2 Reagents: Sodium Hydroxide; 5 Min,Rt2.3 Reagents: Hydrochloric Acid Solvents: Water; Ph 2 - 33.1 Reagents: Hydrochloric Acid Solvents: Methanol,Water; Overnight,Rt3.2 Reagents: Ammonia Solvents: Methanol; 3 H,50 °C3.3 Reagents: Sodium Bicarbonate Solvents: Water; 15 Min,Rt3.4 Solvents: Methanol4.1 Reagents: Cyanuric Chloride,4-Methylmorpholine; 4 H,60 °C4.2 Overnight,Rt4.3 Reagents: Sodium Bicarbonate Solvents: Water; 10 Min,Rt4.4 Solvents: Methanol
    标题:Tct-Mediated Process For The Preparation Of Nafamostat Mesylate And Camostat Mesylate
    作者:Ahmed,Riyaz; Et Al
    参考文献:Chemistryselect 日期:2023 卷标:8(18)]

    = 81525-10-2 + 75-75-2
    反应条件:1.1 Reagents: Hydrogen Peroxide Solvents: Water; < 10 °C; 30 Min,0 °C2.1 Solvents: Peracetic Acid; 0.5 H,0 °C; 0 °C -> Rt; Overnight,Rt3.1 Reagents: Potassium Carbonate Solvents: Water; 0.5 H,Rt3.2 Reagents: Hydrochloric Acid Solvents: Methanol; 0.5 H,Rt4.1 Reagents: Cyanuric Chloride,4-Methylmorpholine; 4 H,60 °C4.2 Overnight,Rt4.3 Reagents: Sodium Bicarbonate Solvents: Water; 10 Min,Rt4.4 Solvents: Methanol
    标题:Tct-Mediated Process For The Preparation Of Nafamostat Mesylate And Camostat Mesylate
    作者:Ahmed,Riyaz; Et Al
    参考文献:Chemistryselect 日期:2023 卷标:8(18)]

    344349-96-8 + 60131-35-3 = 81525-10-2 [标题:Reaction Conditions
    标题:Amidine Compounds And Anticomplement Agent Comprising Them
    参考文献:European Patent Organization]

    58200-88-7 + 42823-46-1 + 75-75-2 = 81525-10-2
    反应条件:1.1 Reagents: Dicyclohexylcarbodiimide Solvents: Pyridine
    标题:Synthesis And Structure-Activity Study Of Protease Inhibitors. Iv. Amidinonaphthols And Related Acyl Derivatives
    作者:Aoyama,Takuo; Et Al
    参考文献:Chemical & Pharmaceutical Bulletin 日期:1985 卷标:33(4) 页码:1458-71
6-脒基-2-萘酚置于吡啶,N,N'-二异丙基碳二亚胺体系中,用 甲醇 作为反应溶剂,化学反应 14.0H,反应生成 萘莫司他
参考文献:Cn117185963
标题:Cn117185963

海关参考信息

专利信息


专利号:US-2025188022-A1
优先权日:2022-02-07
标 题 :Process for the preparation of nafamostat, camostat and their derivatives
发明人:AHMED RIYAZ; KUMAR GULSHAN; MAHAJAN SHEENA; Verma Praveen Kumar; CHAM PANKAJ SINGH; KUMAR AMIT; AHMED QAZI NAVEED; REDDY DUMBALA SRINIVASA; SHANKAR RAVI; SINGH PARVINDER PAL
权利人:COUNCIL SCIENT IND RES
摘要:The invention provides a novel, economical and practical route for the synthesis of an ester from acid and alcoholic functionalities using Trihalotriazine as coupling agent. Specifically, the invention provides a novel, economical and practical route for the preparation of Nafamostat and Camostat. Synthesis of p-guanidinobenzoic acid (Al) was also achieved from thiourea and p-aminobenzoic acid by using trihalotriazine as coupling reagent.

专利号:WO-2008103866-A1
优先权日:2007-02-22
标题 :Synthesis of indoles
发明人:TALLEY JOHN JEFFREY; RENZE JUERGEN T
权利人:MICROBIA INC; TALLEY JOHN JEFFREY; RENZE JUERGEN T
摘要:Method for preparing indoles, including methods that permit high yield production of particular compounds, are described.

专利号:US-9023813-B2
优先权日:2011-04-13
标题:Synthesis and use of glycoside derivatives of propofol
发明人:SHULL BRIAN; BALDWIN JOHN; GOPALASWAMY RAMESH; HAROON ZISHAN
权利人:SHULL BRIAN; BALDWIN JOHN; GOPALASWAMY RAMESH; HAROON ZISHAN; NUTEK PHARMA LTD
摘要:The present invention relates to methods and compositions for the synthesis, production, and use of pro-drug propofol analogs. This invention relates to a method for the production of a broad group of glycosylated propofol carbohydrate derivatives.

专利号:US-2012295866-A1
优先权日:2011-04-13
标题:Synthesis And Use Of Glycoside Pro-Drug Analogs
发明人:SHULL BRIAN; BALDWIN JOHN; GOPALASWAMY RAMESH; HAROON ZISHAN
权利人:SHULL BRIAN; BALDWIN JOHN; GOPALASWAMY RAMESH; HAROON ZISHAN; NUTEK PHARMA LTD
摘要:The present invention relates to methods and compositions for the synthesis, production, and use of pro-drug analogs. This invention relates to a method for the production of a broad group of glycosylated drugs, including but not limited to propofol, acetaminophen, and camptothecin carbohydrate derivatives.

专利号:CN-220143394-U
优先权日:2023-06-21
标题 :A kind of synthesis device for the production of nafamostat mesylate

专利号:US-2012264702-A1
优先权日:2011-04-13
标题 :Synthesis And Use Of Glycoside Derivatives of Propofol
湖南复瑞生物医药技术有限责任公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.furuipharma.com
企业联系电话:13671938786👤
📞湖南复瑞生物医药技术有限责任公司 ⚠️参考联系方式
联系人:戚女士
电话:13671938786
手机:13671938786
传真:QQ:620027714(焦)
邮箱:fay@hn-furui.com,holly@hn-furui.com
通信地址: 湖南省湘潭天易经开区杨柳南路199号
邮编: 411228
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:湖南省湘潭天易经开区杨柳南路199号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Wang W, Zhao J, Zhang X, Wang L, Zhang X, Zhang Z, Qian S. Comparison of Anticoagulant Effects of Nafamostat Mesilate and Heparin in Continuous Renal Replacement Therapy for Patients with High Bleeding Risk: A Meta-Analysis Systemic Review. Kidney Dis (Basel). 2026 Feb 3;12(1):302-317. doi: 10.1159/000550804.
2: Wang Y, He Q, Wen D, Xu R, Yu X, Zhao L. Efficacy and safety of nafamostat mesylate versus heparin anticoagulation in adult kidney disease patients using continuous renal replacement therapy: a systematic review and meta-analysis. Front Med (Lausanne). 2026 Feb 17;13:1713412. doi: 10.3389/fmed.2026.1713412.
3: Liu C, Yang Y, Ren J, Huang Y, Wei W, Li X, Wang F, Tang X, Fu P, Zhang L, Zhao Y. Nafamostat mesilate as anticoagulant for blood purification: a systematic review and meta-analysis. Crit Care. 2025 Dec 24;30(1):43. doi: 10.1186/s13054-025-05813-w.

合成参考文献


摘要:Takahashi H. [Synthetic protease inhibitors for the treatment of DIC]. Rinsho Byori. 2011 Feb;Suppl 147():152–8.
参考文献:10.1097/mpa.0b013e31822116d5
摘要:Park KT, Kang DH, Choi CW, Cho M, Park SB, Kim HW, Kim DU, Chung CW, Yoon KT. Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients Pancreas. 2011 Nov;40(8):1215–9. doi: 10.1097/mpa.0b013e31822116d5.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知